COVID-19 Self-Checker and Monitoring App for Cancer Patients
Own Your Cancer Journey
Get Personalized Advanced Treatment Options
TrialJectory is free for patients
and always will be.
“This is important for every cancer patient to know: You have to advocate for yourself. Don’t take no for an answer too easily”
Dr. Bernard Chinnasami,
Medical Director & Senior Oncologist
“Anyone who has to hear the words ‘you have cancer’ should see what’s a match at TrialJectory right away.”
Hailey Werge,
Breast Cancer patient
Seen in
“Patients with cancer treated in clinical trials lived longer”
Penn State Cancer Institute – 2020 study of 12 million patients
“Cancer patients enrolled in clinical trials receive the best management of care”
-NCCN 2019 Guidelines
How TrialJectory Empowers You
Know YOUR Options
Cancer research is evolving so rapidly that it no longer makes sense for the oncologist to be the gatekeeper of treatment options. TrialJectory creates a personalized list of advanced cancer treatments that match your exact diagnosis.
Tech-Powered Assistance
Our technology analyzes all relevant treatment options and instantly presents only what is a match for your condition in easy to understand language. We remove barriers to becoming a true partner with your oncologist in making decisions about your future.
You’re Not Alone
See the treatment plan of other patients like you. You’ll see how many received the same treatment, the outcome, what other treatments they received, and which advanced treatments they were matched to.
No Big Pharma Bias
Explore options without the influence of drug company and hospital advertising budgets. The company that spends the most on marketing should not determine your cancer treatment.
"TrialJectory researched all cancer treatment options. They've been amazing"
Brenda Shawley
Ready to Start Owning Your Journey?
Select your cancer type
Complete the questionnaire
Receive your personalized list of trials
Compare other patient journeys
Apply to the trial that’s right for you
Get the guidance you need
ONCOLOGY Trials RECRUITING
Community
CAR T Cell Therapy Talk
Did you miss Dr. Joshua Mansour’s webinar? You can view it anytime here. Dr. Joshua Mansour is a board certified hematologist and oncologist with additional training at Stanford in
Myelofibrosis News
Latest News in MF Cancer Research Myelofibrosis (MF) is a rare type of bone marrow cancer that disrupts normal production of blood cells. MF usually develops slowly, and initially
TrialJectory 2020 Review: A Big Step Towards Cancer Patient Empowerment
2020 has been a difficult year for all of us. At times, we have been completely overwhelmed by the COVID-19 pandemic, but throughout, we have persevered to make a difference